http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1080290

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase III|Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, N.I.H., Extramural
endingPage 1832
issn 1479-6694
1744-8301
issueIdentifier 12
pageRange 1827-1832
publicationName Future oncology (London, England)
startingPage 1827
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_007a297afac13737269b359bdade5b7f
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2d1e6553854a4659dd09b476fcc27086
bibliographicCitation Neal JW. The SATURN trial: the value of maintenance erlotinib in patients with non-small-cell lung cancer. Future Oncol. 2010 Dec;6(12):1827–32. PMID: 21142856; PMCID: PMC3042878.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_291483f23eef7690498a95d5fd562cc0
date 201012
identifier https://doi.org/10.2217/fon.10.156
https://pubmed.ncbi.nlm.nih.gov/21142856
https://pubmed.ncbi.nlm.nih.gov/PMC3042878
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32856
https://portal.issn.org/resource/ISSN/1479-6694
https://portal.issn.org/resource/ISSN/1744-8301
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title The SATURN trial: the value of maintenance erlotinib in patients with non-small-cell lung cancer
discusses http://id.nlm.nih.gov/mesh/M0493669
http://id.nlm.nih.gov/mesh/M0593322
http://id.nlm.nih.gov/mesh/M0018336
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D002289Q000188
http://id.nlm.nih.gov/mesh/D066246Q000037
http://id.nlm.nih.gov/mesh/D011799Q000627
http://id.nlm.nih.gov/mesh/D008175Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000069347
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D053208
http://id.nlm.nih.gov/mesh/D017024
http://id.nlm.nih.gov/mesh/D004311
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44263854
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176870
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135410875
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176871

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127377427
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135945851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129159660
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129683629

Total number of triples: 48.